The purpose of this study is to develop a quality improvement intervention to address barriers to evidence-based acute coronary syndrome (ACS) care in northern Tanzania. Patients who presented to Kilimanjaro Christian Medical Center (KCMC) will be asked to complete a survey about barriers and facilitators of health care. In addition the survey will be administered to all providers, policymakers, and administrators participating in in-depth interviews. Data from this survey will be used to develop a quality improvement intervention that will be piloted by KCMC staff. Six months after the pilot program is implemented providers, patients, and administrators will be interviewed for their perspectives on the program.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
641
A quality improvement intervention including reminders, care protocols, and text messages to improve care of myocardial infarction in the KCMC ED
Duke University Hospital
Durham, North Carolina, United States
Acceptability as Measured by the Acceptability of Intervention Measure (AIM)
The AIM tool is a 4-question survey that evaluates the acceptability of an intervention. Responses to each question are on a 5-point Likert Scale (Strongly Agree=5, Agree=4, Neutral=3, Disagree=2, Strongly Disagree=1). Responses of "Strongly Agree" (5) and "Agree" (4) are considered to indicate a more acceptable intervention. The responses to each question will be averaged together to give an acceptability score between 1 and 5 for each respondent. The primary outcome will be the overall mean acceptability score among respondents. A mean acceptability score \>= 4 will be considered to indicate acceptability.
Time frame: Initial ED visit (baseline)
Number of Participants Presenting With Chest Pain or Shortness of Breath Who Undergo ECG and Cardiac Biomarker Testing During Their ED Stay
Time frame: Initial ED visit (baseline)
Survival of Participants With Acute Coronary Syndrome (ACS) at 30 Days After Enrollment
Number of participants with ACS who have survived at 30 days
Time frame: 30 days after enrollment
Number of Participants With Acute Coronary Syndrome (ACS) Taking Aspirin at Baseline
Time frame: Initial ED visit (baseline)
Number of Participants With Acute Coronary Syndrome (ACS) Taking Aspirin 30 Days After Enrollment
Time frame: 30 days after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.